potenti
vector
vaccin
lie
hope
vaccin
would
cheaper
safer
andor
effect
exist
vaccin
pathogen
vaccinia
viru
vector
attract
attent
date
sever
immunogen
insert
genom
without
destroy
infect
b
immunogen
appear
produc
normal
c
vaccinia
viru
use
highli
success
erad
smallpox
wide
hostrang
thu
might
find
veterinari
well
human
medic
applic
experiment
vaccin
success
test
anim
prepar
use
immunogen
influenza
viru
hepat
b
viru
herp
simplex
apathogen
enter
bacteria
potenti
vector
probabl
enter
pathogen
although
potenti
viral
vector
like
realiz
firsl
parasit
worm
protozoa
devast
million
peopl
immunogen
organ
identifi
ad
impetu
investig
potenti
vector
vaccin
pathogen
keyword
vector
bacteri
vector
viral
vector
vaccinia
viru
immunogen
immunogen
mani
year
term
vector
latin
word
carrier
bearer
meant
biologist
agent
transfer
parasit
host
invertebr
vector
come
readili
mind
exampl
mosquito
tsets
fli
transmit
protozoan
caus
malaria
sleepingsick
respect
recent
term
appli
plasmid
manipul
biologist
transfer
select
gene
express
bacteria
yeast
cell
papovaviru
simian
viru
bovin
papilloma
viru
use
vector
conjunct
eukaryot
cell
vector
use
transfer
gene
biolog
entiti
foreign
gene
cell
vitro
either
fundament
research
purpos
product
protein
would
subsequ
purifi
prototyp
vaccin
eg
hepat
b
viru
surfac
antigen
hbsag
yeast
foot
mouth
diseas
viru
vpi
protein
escherichia
coli
logic
step
produc
vector
could
use
immun
anim
directli
foreign
gene
protein
product
immunogen
produc
vivo
potenti
advantag
approach
discuss
later
paper
conveni
shall
use
word
qmmunogen
denot
gene
specifi
product
protein
cours
natur
infect
pathogen
induc
protect
immun
respons
focu
attent
moment
vector
potenti
vaccinia
viru
vaccin
viru
erad
smallpox
viral
standard
vaccinia
viru
dna
genom
enorm
compris
base
pair
vaccinia
viru
gene
essenti
replic
fact
rais
possibl
also
demonstr
marker
rescu
use
anoth
delet
mutant
vaccinia
viru
panicali
paolettp
show
tk
gene
unrel
herp
simplex
viru
hsv
could
insert
genom
infecti
vaccinia
viru
function
tk
enzym
produc
soon
afterward
mackett
et
al
present
similar
find
exploit
tk
gene
vaccinia
viru
hsv
thu
shown
vaccinia
viru
use
select
clone
express
vector
potenti
vector
vaccin
purpos
lost
either
group
subsequ
two
year
sever
paper
publish
illustr
potenti
recombin
vaccinia
viru
form
contain
hbsag
gene
gene
express
vitro
rabbit
vaccin
intraderm
live
recombin
produc
antibodi
hbsag
haemagglutinin
ha
immunogen
influenza
viru
insert
vaccinia
viru
genom
tissu
cultur
cell
infect
recombin
produc
glycosyl
ha
transport
cell
surfac
rabbit
hamster
inocul
recombin
produc
serum
antibodi
neutral
influenza
viru
moreov
hamster
inocul
intraderm
recombin
protect
respiratori
infect
live
influenza
viru
appli
intranas
mice
inocul
intraperiton
vaccinia
viru
recombin
contain
gene
glycoprotein
hsv
resist
lethal
dose
live
hsval
recent
vaccinia
viru
recombin
contain
gene
code
circumsporozoit
antigen
malaria
parasit
plasmodium
knowlesi
made
rabbit
inocul
intraderm
recombin
produc
antibodi
react
extract
p
knowlesi
sporozoit
author
suggest
possibl
express
sever
antigen
differ
life
cycl
stage
parasit
make
potent
vaccin
vaccinia
viru
viru
use
vector
vaccin
sever
eukaryot
virus
establish
potenti
use
vector
eg
adenoviru
bovin
papilloma
viru
herp
viru
retrovirus
howev
point
virus
oncogen
vaccinia
viru
anoth
advantag
vaccinia
viru
use
highli
effect
right
vaccin
erad
smallpox
larg
genom
permit
inclus
larg
amount
dna
construct
stabl
infecti
recombin
contain
base
foreign
dna
claim
american
group
thu
potenti
construct
polyval
vaccin
vaccinia
viru
larg
host
rang
may
make
suitabl
product
vaccin
anim
altern
pox
virus
may
use
poultri
industri
would
seem
suitabl
one
use
vector
chicken
kept
high
stock
densiti
conduc
spread
infecti
diseas
vaccin
drug
essenti
intens
poultri
keep
howev
uk
poultri
industri
spend
turnov
vaccin
profit
margin
slim
inde
much
uk
broiler
grower
sold
loss
thu
vaccin
must
cheap
buy
also
cheap
appli
handl
bird
individu
vaccin
costli
vaccin
current
unavoid
live
vaccin
appli
inexpens
drink
water
spray
gener
induc
good
immun
caus
problem
thu
vaccin
strain
avian
infecti
bronchiti
viru
ibv
coronaviru
caus
damag
oviduct
kidney
chicken
ibv
also
predispos
young
chicken
secondari
infect
strain
ofe
coli
caus
colisepticaemia
multiag
site
vaccin
viru
may
spread
young
chicken
deleteri
effect
inactiv
viru
vaccin
associ
problem
ie
safer
costli
buy
appli
case
ibv
inactiv
viru
alon
induc
good
protect
coccidiosi
chicken
caus
sever
speci
protozoan
eimeria
effect
vaccin
exist
inactiv
vaccin
prepar
induc
protect
vector
approach
may
solut
problem
pathogen
mani
part
world
fowl
pox
problem
live
pox
viru
vaccin
use
control
pox
viru
recombin
carri
immunogen
say
ibv
would
associ
problem
current
live
ibv
vaccin
ie
would
safer
would
still
inexpens
success
protect
hamster
anoth
respiratori
viru
influenza
viru
vaccinia
viru
recombin
carri
influenza
viru
ha
gene
hold
promis
similarli
construct
avian
pox
vaccin
would
protect
chicken
ibv
bacteria
suggest
potenti
vector
immunogen
connect
vaccin
poultri
human
rotavirus
bacterium
chosen
probabl
e
coli
strain
would
nonpathogen
capabl
colon
gastrointestin
tract
time
suffici
permit
protect
immun
respons
mount
immunogen
express
immunogen
bacteri
cell
surfac
would
probabl
induc
better
immun
respons
immunogen
expos
alter
death
bacterium
requir
lot
transport
protein
surfac
bacteria
studi
ii
would
expect
use
enter
bacteri
vector
would
effect
pathogen
gastrointestin
tract
protect
mucos
surfac
might
aris
common
mucos
immun
system
effect
apart
isol
suitabl
bacteria
select
plasmid
transfer
immunogen
obtain
express
bacteri
surfac
potenti
problem
overcom
includ
tendenc
foreign
protein
synthes
bacteria
hydrolys
rapidli
toxic
bacterium
b
lack
ot
glycosyl
may
structur
import
c
possibl
failur
polypeptid
normal
oligomer
protein
assembl
may
result
decreas
antigen
howev
protein
sever
virus
produc
coli
case
fmdv
result
protein
inocul
cattl
swine
protect
challeng
fmdv
murray
et
al
report
prepar
hepat
b
core
antigen
produc
coli
protect
reduc
sever
infect
chimpanze
hepat
b
viru
bacteria
vector
potenti
advantag
warrant
continu
consider
innocu
il
coli
strain
occur
natur
mani
anim
technolog
largescal
product
bacteria
well
develop
bacteria
would
expect
stabl
mani
live
viru
vaccin
stabil
import
attribut
vaccin
administr
would
simpl
inexpens
anim
bacterium
could
ad
lk
od
water
might
vector
chosen
basi
vaccin
first
must
ask
whether
vaccin
pathogen
exist
new
type
vaccin
warrant
recent
broombi
list
number
advantag
product
new
biolog
techniqu
might
simplifi
product
increas
safeti
greater
stabil
improv
potenc
reduc
allergen
patent
new
product
probabl
develop
high
cost
strong
advantag
order
compet
establish
product
recov
cost
vaccin
total
new
may
commerci
attract
eg
coccidiosi
poultri
endoand
ectoparasit
herp
simplex
viru
vectorbas
vaccin
may
cheapli
produc
safer
current
vaccin
exampl
hepat
b
viru
ibv
respect
new
approach
vaccin
product
current
investig
synthesi
protein
peptid
bacteria
yeast
eukaryot
cell
chemic
synthesi
peptid
ration
manipul
viru
genom
develop
suitabl
adjuv
although
unlik
vector
approach
suitabl
diseas
sever
major
potenti
advantag
stem
experiment
observ
immunogen
transfer
vaccinia
viru
gene
express
immunogen
properti
similar
immunogen
deriv
parent
viru
inocul
anim
respond
protect
immun
respons
especi
excit
protect
lower
respiratori
tract
hamster
infect
influenza
viru
follow
intraderm
inocul
vaccinia
viru
recombin
carri
influenza
viru
ha
gene
product
ofimmunogen
infect
cell
follow
use
live
poxviru
vector
might
stimul
much
comprehens
array
immun
respons
would
aris
tbllow
parenter
administr
inactiv
viru
subunit
vaccin
transport
immunogen
surfac
cell
may
case
necessari
induct
effici
protect
immun
respons
advantag
ofvaccinia
viru
use
vaccin
mani
year
experi
medic
commun
worldwid
littl
expertis
requir
administr
success
elimin
smallpox
beyond
disput
howev
misgiv
express
number
peopl
vaccin
vaccinia
viru
seriou
complic
led
death
survey
undertaken
usa
indic
risk
death
vaccin
complic
primari
vaccine
one
per
million
vaccine
age
b
five
per
million
vaccine
month
age
c
per
million
vaccine
year
old
addit
combin
rate
postvaccini
enceph
vaccinia
necrosum
per
million
infant
three
per
million
age
year
figur
must
taken
account
consider
given
use
vaccinia
viru
vector
howev
pathogen
afflict
mankind
much
greater
scale
parasit
worm
helminth
infect
million
peopl
african
contin
alon
million
peopl
affect
malaria
caus
one
million
death
per
year
estim
million
peopl
affect
hepat
b
viru
terribl
figur
demand
vaccin
develop
apart
safe
efficaci
must
cheap
produc
administ
vector
vaccin
base
vaccinia
viru
would
seem
suitabl
approach
challeng
especi
develop
countri
vector
immunogen
cavanagh
diseas
problem
greatest
abil
pay
least
suggest
vector
approach
gener
use
pox
virus
particular
panacea
outstand
vaccin
problem
nevertheless
approach
great
potenti
warrant
investig
immunogen
mani
pathogen
f
one
human
one
veterinari
vaccin
success
base
vector
gain
mankind
could
enorm
